Anticancer potential of curcumin: preclinical and clinical studies
- PMID: 12680238
Anticancer potential of curcumin: preclinical and clinical studies
Abstract
Curcumin (diferuloylmethane) is a polyphenol derived from the plant Curcuma longa, commonly called turmeric. Extensive research over the last 50 years has indicated this polyphenol can both prevent and treat cancer. The anticancer potential of curcumin stems from its ability to suppress proliferation of a wide variety of tumor cells, down-regulate transcription factors NF-kappa B, AP-1 and Egr-1; down-regulate the expression of COX2, LOX, NOS, MMP-9, uPA, TNF, chemokines, cell surface adhesion molecules and cyclin D1; down-regulate growth factor receptors (such as EGFR and HER2); and inhibit the activity of c-Jun N-terminal kinase, protein tyrosine kinases and protein serine/threonine kinases. In several systems, curcumin has been described as a potent antioxidant and anti-inflammatory agent. Evidence has also been presented to suggest that curcumin can suppress tumor initiation, promotion and metastasis. Pharmacologically, curcumin has been found to be safe. Human clinical trials indicated no dose-limiting toxicity when administered at doses up to 10 g/day. All of these studies suggest that curcumin has enormous potential in the prevention and therapy of cancer. The current review describes in detail the data supporting these studies.
Similar articles
-
Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent.Mol Nutr Food Res. 2008 Jun;52 Suppl 1:S103-27. doi: 10.1002/mnfr.200700238. Mol Nutr Food Res. 2008. PMID: 18496811 Review.
-
Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.Phytomedicine. 2012 Sep 15;19(12):1085-92. doi: 10.1016/j.phymed.2012.07.002. Epub 2012 Aug 22. Phytomedicine. 2012. PMID: 22921746
-
Curcumin as "Curecumin": from kitchen to clinic.Biochem Pharmacol. 2008 Feb 15;75(4):787-809. doi: 10.1016/j.bcp.2007.08.016. Epub 2007 Aug 19. Biochem Pharmacol. 2008. PMID: 17900536 Review.
-
Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.Mol Pharmacol. 2006 Jan;69(1):195-206. doi: 10.1124/mol.105.017400. Epub 2005 Oct 11. Mol Pharmacol. 2006. PMID: 16219905
-
New mechanisms and therapeutic potential of curcumin for colorectal cancer.Mol Nutr Food Res. 2008 Sep;52(9):1040-61. doi: 10.1002/mnfr.200700280. Mol Nutr Food Res. 2008. PMID: 18655004 Review.
Cited by
-
The curative and mechanistic acumen of curcuminoids formulations against haloperidol induced Parkinson's disease animal model.Metab Brain Dis. 2023 Mar;38(3):1051-1066. doi: 10.1007/s11011-022-01122-1. Epub 2022 Nov 28. Metab Brain Dis. 2023. PMID: 36437394
-
Photodynamic Action of Curcumin and Methylene Blue against Bacteria and SARS-CoV-2-A Review.Pharmaceuticals (Basel). 2023 Dec 25;17(1):34. doi: 10.3390/ph17010034. Pharmaceuticals (Basel). 2023. PMID: 38256868 Free PMC article. Review.
-
Antioxidant activities of curcumin in allergic rhinitis.Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3765-3773. doi: 10.1007/s00405-016-4076-4. Epub 2016 May 4. Eur Arch Otorhinolaryngol. 2016. PMID: 27146978
-
Use of Time-Resolved Fluorescence to Monitor Bioactive Compounds in Plant Based Foodstuffs.Biosensors (Basel). 2015 Jun 26;5(3):367-97. doi: 10.3390/bios5030367. Biosensors (Basel). 2015. PMID: 26132136 Free PMC article. Review.
-
Effects of curcumin on the proliferation and mineralization of human osteoblast-like cells: implications of nitric oxide.Int J Mol Sci. 2012 Nov 29;13(12):16104-18. doi: 10.3390/ijms131216104. Int J Mol Sci. 2012. PMID: 23443113 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous